Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Total Liabilities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Total Liabilities for 9 consecutive years, with $19.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 36.68% to $19.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.0 million, a 36.68% increase, with the full-year FY2024 number at $16.0 million, up 67.8% from a year prior.
  • Total Liabilities was $19.0 million for Q3 2025 at Catheter Precision, roughly flat from $19.0 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $19.0 million in Q3 2025 to a low of -$9.8 million in Q2 2022.
  • A 5-year average of $10.0 million and a median of $10.1 million in 2021 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: plummeted 224.0% in 2022, then surged 220.02% in 2023.
  • Catheter Precision's Total Liabilities stood at $7.4 million in 2021, then increased by 2.78% to $7.6 million in 2022, then increased by 25.96% to $9.5 million in 2023, then surged by 67.8% to $16.0 million in 2024, then grew by 18.8% to $19.0 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Total Liabilities are $19.0 million (Q3 2025), $19.0 million (Q2 2025), and $16.9 million (Q1 2025).